Reduces risk for heart failure and cardiovascular disease hospitalizations.
Drug able to treat 18,000 people will cost over $300k per year.
Drug shortages might be decreasing, but their continued existence is urging the pharmacy industry to maintain its vigilance.
Available for prescribing starting January 2020
First approved in 2018 for patients 12 years of age and older.
Education can help pharmacists feel more comfortable dispensing care.
Originally approved in 1995 for use in adults only.
Job growth may stagnate and retail jobs continue to dwindle.
Results of multi-generational study indicates risk reduction potential.
Study shows that efficacy is a major concern.